Odonate Therapeutics reports Q4 EPS (87c), consensus (78c)
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Aligos Therapeutics reports Q4 ($1.09) EPS , consensus (82c)
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Entasis Therapeutics reports 2020 EPS ($2.10), consensus ($2.39)
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Odonate Therapeutics reports discontinuation of Tesetaxel development
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Odonate Therapeutics reports discontinuation of Tesetaxel development
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Sigilon Therapeutics reports Q4 EPS ($1.15), consensus ($1.37)
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
ADC Therapeutics reports Q4 adjusted EPS (82c), consensus (38c)
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
ADC Therapeutics reports Q4 EPS (73c), consensus (38c)
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Applied Therapeutics reports 2020 EPS ($4.28), consensus ($4.53)
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Aprea Therapeutics reports Q4 EPS (73c), consensus (64c)
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Pliant Therapeutics reports Q EPS (54c), consensus (71c)
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Prelude Therapeutics reports Q4 EPS (45c), consensus (47c)
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Akero Therapeutics reports Q4 EPS (86c), consensus (59c)
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Ovid Therapeutics reports Q4 EPS (34c), consensus (31c)
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Beam Therapeutics reports Q4 EPS ($1.69), consensus (67c)
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Spero Therapeutics reports Q4 EPS (68c), consensus (74c)
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Lineage Cell Therapeutics reports Q4 EPS (1c), consensus (5c)
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Poseida Therapeutics reports Q4 EPS (58c), consensus (69c)
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Rapt Therapeutics reports Q4 EPS (52c), consensus (59c)
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Protara Therapeutics reports Q4 EPS (79c), consensus (54c)
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
BioXcel Therapeutics reports Q4 EPS (87c), consensus (96c)
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»